Impact of informative censoring on estimation and testing in randomized trials with delayed treatment effects

被引:0
|
作者
Lin, Jingyi [1 ,3 ]
Zhao, Yujie [1 ]
Chen, X. Gregory [2 ]
Donica, Margarita [2 ]
Leon, Larry
Trinquart, Ludovic [3 ,4 ,5 ]
Wan, Shuyan Sabrina [1 ]
机构
[1] Merck & Co Inc, Biostat & Res Decis Sci, Rahway, NJ 07065 USA
[2] MSD Innovat & Dev GmbH, Biostat & Res Decis Sci, Zurich, Switzerland
[3] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA
[4] Tufts Univ, Tufts Clin & Translat Sci Inst, Boston, MA USA
[5] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA USA
关键词
Informative censoring; Randomized clinical trial; Coupla; Nonproportional hazard ratio; Survival analysis; PROGRESSION-FREE SURVIVAL; INVERSE-PROBABILITY; RANK; NONCOMPLIANCE; SENSITIVITY; ASSUMPTION; TIME;
D O I
10.1016/j.cct.2025.107860
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Time-to-event endpoints like progression-free survival in oncology randomized trials sometimes demonstrate differential censoring patterns between study arms which can be indicative of informative censoring, depending on censoring reasons. Informative censoring can bias treatment effect estimates but few simulation studies characterized the magnitude of its impact, particularly in the context of therapies with delayed treatment effects. We used copula methods to model dependent censoring data and assessed the impact of informative censoring. To improve the understanding of copula models in this context, we proposed a new measure of the strength of informative censoring, the probability of events being informatively censored. We further proposed a visual tool for examining the underlying correlation pattern between censoring and event time. We conducted simulation studies to assess the impact of informative censoring on estimation bias for hazard ratios, as well as on empirical power of unweighted, weighted log-rank tests, and the MaxCombo test. We implemented data generation algorithm for copula survival models with piece-wise exponential marginals to introduce various censoring patterns under scenarios with delayed treatment effect. We found large overestimation of hazard ratio of the experimental arm versus the control arm and loss in power when there was a positive correlation between event time and censoring time in the control arm and a negative correlation in the experimental arm. When correlations in both arms were of the same direction and degree, we observed minimal impact on hazard ratio estimate and statistical powers.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Impact of informative censoring on the treatment effect estimate of disability worsening in multiple sclerosis clinical trials
    Riester, Katherine
    Kappos, Ludwig
    Selmaj, Krzysztof
    Lindborg, Stacy
    Lipkovich, Ilya
    Elkins, Jacob
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 39
  • [2] Semiparametric estimation of treatment effect with time-lagged response in the presence of informative censoring
    Xiaomin Lu
    Anastasios A. Tsiatis
    Lifetime Data Analysis, 2011, 17 : 566 - 593
  • [3] Semiparametric estimation of treatment effect with time-lagged response in the presence of informative censoring
    Lu, Xiaomin
    Tsiatis, Anastasios A.
    LIFETIME DATA ANALYSIS, 2011, 17 (04) : 566 - 593
  • [4] Informative censoring due to missing data in quality of life was inadequately assessed in most oncology randomized controlled trials
    Olivier, Timothee
    Haslam, Alyson
    Prasad, Vinay
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2021, 139 : 80 - 86
  • [5] Assessing differential informative censoring in control and experimental arm in trials testing immunotherapy in metastatic cancers: A systematic review
    Vitale, F.
    Salomone, F.
    D'Ambrosio, S.
    Avanzo, A.
    Viggiano, A.
    Liguori, L.
    Napolitano, F.
    Santaniello, A.
    Formisano, L.
    Bianco, R.
    Servetto, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S705 - S705
  • [6] How serious is bias in effect estimation in randomised trials with survival data given risk heterogeneity and informative censoring?
    McNamee, Roseanne
    STATISTICS IN MEDICINE, 2017, 36 (21) : 3315 - 3333
  • [7] Inference for the Effect of Treatment on Survival Probability in Randomized Trials with Noncompliance and Administrative Censoring
    Nie, Hui
    Cheng, Jing
    Small, Dylan S.
    BIOMETRICS, 2011, 67 (04) : 1397 - 1405
  • [8] Conditional and Unconditional Treatment Effects in Randomized Clinical Trials: Estimands, Estimation, and Interpretation
    Wei, Jiawei
    Xu, Jiajun
    Bornkamp, Bjorn
    Lin, Ray
    Tian, Hong
    Xi, Dong
    Zhang, Xin
    Zhao, Ziqiang
    Roychoudhury, Satrajit
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2024, 16 (03): : 371 - 381
  • [9] Estimation of treatment effects in randomized trials with non-compliance and a dichotomous outcome
    van der Laan, Mark J.
    Hubbard, Alan
    Jewell, Nicholas P.
    JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 2007, 69 : 463 - 482
  • [10] A BIAS CORRECTION IN TESTING TREATMENT EFFICACY UNDER INFORMATIVE DROPOUT IN CLINICAL TRIALS
    Kong, Fanhui
    Chen, Yeh-Fong
    Jin, Kun
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2009, 19 (06) : 980 - 1000